PFS
NMTR

Prospera Financial Services’s 9 Meters Biopharma NMTR Stock Holding History

Prospera Financial Services’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,400
Closed -$6K – 973
2022
Q3 		$6K Hold
1,400
– – ﹤0.01% 828
2022
Q2 		$7K Buy
1,400
+400
+40% +$3.77K ﹤0.01% 1423
2022
Q1 		$12K Buy
1,000
+150
+18% +$2.05K ﹤0.01% 1979
2021
Q4 		$17K Sell
850
-200
-19% -$4.47K ﹤0.01% 863
2021
Q3 		$27K Hold
1,050
– – ﹤0.01% 790
2021
Q2 		$23K Hold
1,050
– – ﹤0.01% 788
2021
Q1 		$24K Buy
1,050
+300
+40% +$9.22K ﹤0.01% 743
2020
Q4 		$13K Hold
750
– – ﹤0.01% 668
2020
Q3 		$12K Buy
+750
New +$9.09K ﹤0.01% 1075

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Prospera Financial Services's NMTR Position: Q4 2022 in Review

Prospera Financial Services sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 1,400 shares — an estimated $6K sold.

Prospera Financial Services first reported a position in NMTR in Q3 2020 and held it in 9 quarters. The position peaked at $27K in Q3 2021. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • Prospera Financial Services reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
  • Prospera Financial Services sold 1,400 9 Meters Biopharma shares in Q4 2022, an estimated $6K.
  • Prospera Financial Services first reported a position in 9 Meters Biopharma in Q3 2020 and held it in 9 quarters.
  • Prospera Financial Services's 9 Meters Biopharma position peaked at $27K in Q3 2021.
  • 42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on Prospera Financial Services's 13F filing for Q4 2022, filed 8 Feb 2023.